GlycoMimetics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.13 | $34.40 M | -0.75 | 22 |
MLYS
Mineralys Therapeutics, Inc. |
$14.92 | $971.76 M | -3.98 | 51 |
BCAB
BioAtla, Inc. |
$0.43 | $25.02 M | -0.35 | 61 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 |
FHTX
Foghorn Therapeutics Inc. |
$4.54 | $252.51 M | -3.51 | 112 |
DYN
Dyne Therapeutics, Inc. |
$14.46 | $1.64 B | -4.01 | 192 |
CUE
Cue Biopharma, Inc. |
$0.64 | $48.90 M | -1.01 | 41 |
ASMB
Assembly Biosciences, Inc. |
$17.10 | $131.10 M | -2.77 | 73 |
SPRO
Spero Therapeutics, Inc. |
$2.89 | $161.58 M | -2.26 | 32 |
TIL
Instil Bio, Inc. |
$37.51 | $244.95 M | -3.12 | 14 |
TRVI
Trevi Therapeutics, Inc. |
$6.17 | $735.12 M | -13.71 | 31 |
ACHL
Achilles Therapeutics plc |
$0.00 | $60.83 M | -0.89 | 204 |
IVA
Inventiva S.A. |
$3.38 | $175.70 M | -0.96 | 114 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
